Yes, there are several cheaper alternatives to Janumet, and the right one depends on your insurance situation, your blood sugar goals, and how much you’re willing to trade in side effects for a lower price. Brand-name Janumet runs about $330 for a 60-tablet supply (a month’s worth at the typical twice-daily dose), and even the generic version still costs around $246 for the same quantity. That’s a significant expense, especially without insurance.
Janumet is a combination pill containing two active ingredients: sitagliptin (a DPP-4 inhibitor that helps your body produce more insulin after meals) and metformin (the most widely prescribed diabetes drug in the world). Understanding that it’s two drugs in one opens up your options.
Metformin Alone May Be Enough
The metformin half of Janumet is available as a standalone generic for as little as $4 to $10 per month at many pharmacies. If your blood sugar was reasonably well controlled before sitagliptin was added, it’s worth asking your prescriber whether metformin alone, possibly at a higher dose, could still keep your numbers in range. Metformin remains the first-line medication for type 2 diabetes in virtually every major guideline, and for many people it does the job on its own for years.
Sulfonylureas: The Classic Budget Option
If metformin alone isn’t enough, the most common low-cost add-on is a sulfonylurea, a class of drugs that includes glipizide, glimepiride, and glyburide. These are available as generics for a few dollars a month and have been used for decades. They lower A1c by a similar amount as sitagliptin when added to metformin.
The trade-off is real, though. In a large meta-analysis comparing DPP-4 inhibitors (the class sitagliptin belongs to) against sulfonylureas as add-on therapy to metformin, sulfonylureas caused significantly more hypoglycemia: 20% to 27% of patients experienced low blood sugar episodes over one to two years, compared to just 3% to 6% with DPP-4 inhibitors. Sulfonylureas also tend to cause weight gain, while DPP-4 inhibitors are associated with modest weight loss. Over two years, patients on DPP-4 inhibitors were about 50% more likely to reach an A1c below 7% without any hypoglycemia episodes.
A European cost-effectiveness analysis found that a sitagliptin-based strategy cost roughly €1,100 more per patient over a lifetime than a sulfonylurea-based strategy, with the extra cost driven almost entirely by prescription drug prices. That translated to a small gain in quality-adjusted life expectancy, mainly from fewer low blood sugar events, less weight gain, and a slightly lower heart attack risk. Whether that trade-off makes sense depends on your budget and your personal risk factors. If you’re prone to low blood sugar or already struggling with weight, sulfonylureas deserve extra caution.
Newer Drug Classes Worth Discussing
The 2025 American Diabetes Association standards recommend prioritizing medications that offer benefits beyond blood sugar control, particularly for heart health, kidney protection, and weight management. Two drug classes stand out: SGLT2 inhibitors (which help your kidneys flush out excess sugar) and GLP-1 receptor agonists (injectable or oral medications that mimic a gut hormone involved in blood sugar regulation). Both classes are now available in some generic or lower-cost forms depending on your pharmacy and insurance plan, and both offer cardiovascular and kidney benefits that DPP-4 inhibitors like sitagliptin do not.
The ADA guidelines actually recommend stopping DPP-4 inhibitors (along with sulfonylureas) when possible, because they lack the additional heart, kidney, weight, and liver benefits that newer options provide. If cost is pushing you to reconsider Janumet anyway, this may be a good time to talk with your prescriber about whether an SGLT2 inhibitor or GLP-1 agonist paired with cheap generic metformin could serve you better overall.
Splitting Janumet Into Two Separate Pills
Since Janumet is just sitagliptin and metformin combined, you could theoretically take each ingredient as a separate tablet. Generic metformin is extremely cheap. However, sitagliptin (brand name Januvia) on its own is still an expensive branded medication, so splitting the pills doesn’t necessarily save money. The savings from this approach depend entirely on whether your pharmacy or insurance offers a better deal on the individual components than on the combination. It’s worth asking your pharmacist to run both options through your plan.
Manufacturer Assistance for Janumet
If you’d prefer to stay on Janumet, Merck (the manufacturer) runs a patient assistance program that can provide the medication at no cost. You may qualify if you meet all three criteria: you’re a U.S. resident with a valid prescription, you don’t have insurance or other prescription coverage (including Medicaid, Medicare, or VA benefits), and your household income falls below certain thresholds. Those thresholds are $63,840 for an individual, $86,560 for a couple, or $132,000 for a family of four. Even if you don’t meet the insurance requirement, Merck allows exception requests for cases involving financial and medical hardship. You can apply through merckhelps.com or call 1-800-727-5400.
How to Choose the Right Alternative
Your decision comes down to a few practical questions. If your main concern is monthly cost and you tolerate some risk of low blood sugar, a sulfonylurea plus generic metformin is the cheapest proven combination, often under $15 a month total. If you want to avoid low blood sugar and weight gain, a DPP-4 inhibitor like sitagliptin is gentler but more expensive. If you have heart disease, kidney disease, or significant excess weight, an SGLT2 inhibitor or GLP-1 agonist paired with metformin may be the smartest long-term choice regardless of price, and some plans now cover these preferentially.
Bring your cost concerns directly to your prescriber. Diabetes medication decisions always involve balancing blood sugar control, side effects, other health conditions, and affordability. Your doctor can’t factor in cost if they don’t know it’s an issue, and in many cases, a less expensive regimen works just as well.